1. 100 INTERNATIONAL, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF CC-486 (ORAL AZACITIDINE) IN PATIENTS WITH IPSS INTERMEDIATE-1 MYELODYSPLASTIC SYNDROMES WITH RBC-TRANSFUSION-DEPENDENT ANEMIA AND THROMBOCYTOPENIA: THE QUAZAR LOWER-RISK MDS TRIAL. Issue 1 (April 2015) Authors: Garcia-Manero, G.; Platzbecker, U.; Santini, V.; Voso, M.T.; Garcia, R.; Valcarcel, D.; Silverman, L.R.; Almeida, A.; Giagounidis, A.; Larsen, S.R.; Kreitz, S.; Hoenekopp, A.; Skikne, B.S. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 107 MONITORING OF THERAPEUTIC RESPONSE TO LENALIDOMIDE IN DEL(5Q) MDS USING A RAPID 5-PARAMETER FLOW CYTOMETRIC DEL(5Q)-SCORE. Issue 1 (April 2015) Authors: Oelschlaegel, U.; Mohr, B.; Sockel, K.; Thiede, C.; Ehninger, G.; Bornhäuser, M.; Platzbecker, U. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 109 CLINICAL AND MOLECULAR PREDICTORS OF RESPONSE TO ERYTHROPOIESIS STIMULATING AGENTS (ESA) IN LOWER RISK MDS PATIENTS. (April 2015) Authors: Kosmider, O.; Passet, M.; Santini, V.; Platzbecker, U.; Andrieu, V.; Zini, G.; Beyne-Rauzy, O.; Guerci, A.; Slama, B.; Fenaux, P.; Dreyfus, F.; Fontenay, M.; Park, S. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 112 RANDOMIZED PHASE III STUDY OF IV RIGOSERTIB VERSUS BEST SUPPORTIVE CARE (BSC) IN PATIENTS WITH HIGHER-RISK MDS (HR-MDS) AFTER FAILURE OF HYPOMETHYLATING AGENTS (HMAS). (April 2015) Authors: Garcia-Manero, G.; Fenaux, P.; Al-Kali, A.; Baer, M.R.; Sekeres, M.; Roboz, G.; Gaidano, G.; Scott, B.; Greenberg, P.; Platzbecker, U.; Steensma, D.P.; Kambhampati, S.; Kreuzer, K.A.; Godley, L.; Collins, R.; Atallah, E.; Azarnia, N.; Petrone, M.E.; Snyder, B.R.; Maniar, M. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 117 A PHASE 3 STUDY OF LENALIDOMIDE VERSUS PLACEBO IN RBC TRANSFUSION-DEPENDENT (TD) PATIENTS WITH LOWER-RISK MDS WITHOUT DEL(5Q) UNRESPONSIVE OR REFRACTORY TO ERYTHROPOIESIS-STIMULATING AGENTS (ESAS). Issue 1 (April 2015) Authors: Santini, V.; Almeida, A.; Giagounidis, A.; Gröpper, S.; Jonasova, A.; Vey, N.; Mufti, G.J.; Buckstein, R.; Mittelman, M.; Platzbecker, U.; Shpilberg, O.; Ram, R.; del Canizo, C.; Gattermann, N.; Ozawa, K.; Risueno, A.; MacBeth, K.J.; Zhong, J.; Séguy, F.; Hoenekopp, A. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 120 RESULTS OF THE MULTICENTER, PHASE II STUDY OF THE SAFETY OF LENALIDOMIDE MONOTHERAPY IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) ASSOCIATED WITH AN ISOLATED DEL(5Q). Issue 1 (April 2015) Authors: Schuler, E.; Schemenau, J.; Giagounidis, A.; Haase, D.; Büsche, G.; Platzbecker, U.; Nolte, F.; Götze, K.; Schlenk, R.F.; Ganser, A.; Letsch, A.; Lübbert, M.; Schafhausen, P.; Bug, G.; Germing, U. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 240 DYSPLASIAS REVISITED – CONSIDERATIONS FOR A MULTIDIMENSIONAL APPROACH TO HETEROGENEITY OF MDS: DATA ON 1979 PATIENTS FROM THE GERMAN AUSTRIAN DATA BASE. Issue 1 (April 2015) Authors: Pfeilstöcker, M.; Tuechler, H.; Nachtkamp, K.; Platzbecker, U.; Schönmetzler, A.; Sperr, W.; Stauder, R.; Strupp, C.; Valent, P.; Germing, U. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 318 THE IPSS-R HAS PROGNOSTIC IMPACT IN UNTREATED PATIENTS WITH MDS DEL(5Q). Issue 1 (April 2015) Authors: Schemenau, J.; Lauseker, M.; Hildebrandt, B.; Fenaux, P.; Pfeilstöcker, M.; Valent, P.; Platzbecker, U.; Kündgen, A.; Bug, G.; Haas, R.; Germing, U. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 37 CAR, A NOVEL MEDIATOR OF ERYTHROID DIFFERENTIATION AND MIGRATION, IS SPECIFICALLY DOWNREGULATED IN ERYTHROPOIETIC PROGENITOR CELLS IN MDS. (April 2015) Authors: Bauer, K.; Machherndl-Spandl, S.; Suessner, S.; Danzer, M.; Proell, J.; Lauf, J.; Eisenwort, G.; Sperr, W.; Klein, H.; Hoermann, G.; Haefner, N.; Bene, M.; Platzbecker, U.; Weltermann, A.; Gabriel, C.; Lion, T.; Germing, U.; Bettelheim, P.; Valent, P. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 53 LUSPATERCEPT INCREASES HEMOGLOBIN AND REDUCES TRANSFUSION BURDEN IN PATIENTS WITH LOW OR INTERMEDIATE-1 RISK MYELODYSPLASTIC SYNDROMES (MDS): PRELIMINARY RESULTS FROM A PHASE 2 STUDY. (April 2015) Authors: Platzbecker, U.; Germing, U.; Giagounidis, A.; Götze, K.; Kiewe, P.; Mayer, K.; Ottmann, O.; Radsak, M.; Wolff, T.; Haase, D.; Hankin, M.; Wilson, D.; Zhang, X.; Laadem, A.; Sherman, M.; Attie, K. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗